Clinical Trial Update: An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) [Phase 1, Phase 2]

View source ↗

Summary

This document notes a Phase 1/2 clinical trial evaluating NTB003 for thyroid eye disease, which is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• NTB003

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: Thyroid Eye Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING